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Myocardial Catecholamines in Hypertrophic and Dilated (Congestive)
Cardiomyopathy: A Biopsy Study
CHUICHI KAWAI, MD, FACC, YOSHIKI YUI, MD, TSUNEO HOSHINO, MD,
SHIGETAKE SASAYAMA, MD, FACC, AKIRA MATSUMORI, MD
Kyoto. Japan
A high performance liquid chromatographic method was
used to determine myocardial norepinephrine and epi-
nephrine concentrations in 66 biopsyspecimens obtained
from the right or left ventricle during routine diagnostic
cardiac catheterization of 45 patients with dilated
(congestive) or hypertrophic cardiomyopathy, or with
heart disease other than cardiomyopathy, such as acute
perimyocarditis, postmyocarditis and constrictive peri-
carditis. The validity of catecholamine determination in
a 2 to 6 mg biopsy specimen to assess overall ventricular
myocardial catecholamines was demonstrated.
Norepinephrine concentrations in the myocardium
were inversely correlated with the grade of hypertrophy
in patients with congestivecardiomyopathy or heart dis-
ease other than cardiomyopathy, but not in patients with
hypertrophic cardiomyopathy. The fact that the myo-
The term" noradrenosis" was proposed by Pearse (1) in 1964
to describe a significant increase in the level of fluorescent
noradrenaline in myocardial specimens removed at opera-
tion from the outflow tract of the left ventricle in patients
with hypertrophic obstructive cardiomyopathy. However,
the hypothesis of an increased noradrenaline content and
augmented sympathetic nerve supply to the interventricular
septal myocardium in cases of hypertrophic obstructive car-
diomyopathy has not been substantiated. In 1971, Van
Noorden et a1. (2) failed to confirm the presence of noradren-
aline by microspectrofluorimetric methods in samples of
myocardium obtained from the area of greatest obstruction
during open heart surgery in cases of hypertrophic obstruc-
From the Third Division, Department of Internal Medicine, Faculty of
Medicine, Kyoto University, Kyoto, Japan. This study was supported in
part by Research Grants for Cardiomyopathy and for Cardiovascular Dis-
eases (56-c) from the Mirustry of Health and Welfare, and Scientific Re-
search Grants 357308(1978), 444044, 448215(1979), 587066(1980),
440045(1981) from the Ministry of Education, Science and Culture, Tokyo,
Japan. Manuscript received February I, 1983; revised manuscript received
June 6, 1983, accepted June 8, 1983.
Address for reprints: Chuichi Kawai, MD, Third Division, Department
of Internal Medicine, Kyoto University Hospital, 54 Kawaracho Shogoin,
Sakyoku, Kyoto 606, Japan.
© 1983 by the Amencan College of Cardiology
cardial norepinephrine concentration was always lower
in the left than in the right ventricle of the same patient
may be explained by the simple dilution of sympathetic
nerve endings in the left ventricle.
There were some cases of hypertrophic cardio-
myopathy in which the concentration of myocardial nor-
epinephrine was exceptionally high, although its mean
value was not significantly higher than that in patients
with other types of heart disease who served as a control
group without cardiomyopathy. Some patients with di-
lated cardiomyopathy had lower levels of myocardial
norepinephrine than would be expected for the degree
of interstitial fibrosis and the severity of heart failure.
The mean plasma norepinephrine and epinephrine levels
were significantly elevated in patients with dilated
cardiomyopathy.
tive cardiomyopathy. However, the myocardial noradren-
aline content of patients with congestive cardiomyopathy
has never been reported, because these patients rarely undergo
cardiac surgery.
This report describes the myocardial catecholamines in
biopsy specimens removed from the right and left ventricles
during diagnostic cardiac catheterization in an attempt to
elucidate the role of myocardial catecholamines and sym-
pathetic nervous activity in the pathogenesis of cardio-
myopathy.
Methods
Patients. Biopsy specimens were obtained during rou-
tine diagnostic cardiac catheterization after premedication
with 5 mg of diazepam (Cercine). Specimens were taken
from the right ventricular side of the septum or left ven-
tricular free wall, or both, by the Konno-Sakakibara (3) or
Kawai (4) biopsy catheter in 34 patients with cardio-
myopathy (10 congestive [dilated] and 24 hypertrophic) and
in 11 patients with other types of heart disease (2 with acute
perimyocarditis, 6 with postmyocarditis, 1 with constrictive
pericarditis, 1 with coronary arteriovenous fistula and 1 with
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Figure 1. A representative catecholamme chromatogram of biop-
Sled myocardium obtained from a patient with hypertrophic car-
diomyopathy (HeM) (right) and that of a standard sample con-
taining a known amount of catecholarnines (left), Epi = epinephrine;
NE = norepinephrine,
crometer disc with a linear scale, and the average cell di-
ameter of each specimen was calculated,
Fibrosis was graded as follows: Grade 0 signified no
apparent fibrosis with the exception of small islets of fibrous
tissue around the capillaries, Focal and minimal fibrosis was
grade I and moderate to severe fibrosis of nearly 30 to 50%
of the area of the entire specimen was classified as grade
II. All the histologic studies were performed by observers
who were ignorant of the source of the specimen.
Statistical analysis. Paired or unpaired t tests and anal-
yses of variance followed by multiple comparison tests were
used in the statistical analysis, Values are expressed as the
mean ± standard deviation. Statistical significance is de-
fined as a probability (p) value of less than 0,05,
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Results
Reliability, reproducibility andsensitivity of themethod
for determining myocardial catecholamine concentra-
tion. There was a linear relation between fluorescence in-
tensity (peak height) and catecholamine concentration from
oto 1,000 pg, the highest concentration tested. Within-run
and day to day coefficients of variation were 1.0 and 1,6%
for norepinephrine and 1.0 and 1.8% for epinephrine, re-
spectively (n = 10), A significant correlation (p < 0.001)
was observed between measurements (n = 10) in the two
assays for both norepinephrine (correlation coefficient [r]
= 0.98) and epinephrine (r = 0.94). Analytical recovery
of norepinphrine and epinephrine on the basis of the recov-
ery rate from samples fortified with 100 pg of each standard
catecholamine was about 100%. With this chromatographic
system, the lowest detection limit for each catecholamine
in the myocardium is about 10 pg.
Figure 1 (right panel) shows a representative catechol-
amine chromatogram of a myocardial biopsy specimen from
the left ventricle of a patient with hypertrophic cardio-
myopathy. The left panel demonstrates the standard sample
containing 200 pg of norepinephrine and epinephrine, Con-
alcoholism), The use of any catecholamine or vasodilating
agent was forbidden for either therapeutic or diagnostic pur-
poses for a least 24 hours before the procedure, The diag-
nosis of congestive (dilated) and hypertrophic cardio-
myopathy was made according to the definition and clas-
sification proposed by the World Health Organization/
International Society and Federation of Cardiology task force
(5). The last group of patients served as a control group
without cardiomyopathy. All the patients gave written con-
sent before the study.
Catecholamine determination in myocardial biopsy
specimens. Biopsy specimens, weighing approximately 2
to 6 mg, were divided into two parts: one for histologic
study and the other for catecholamine determination by high
performance liquid chromatography which has been devel-
oped recently in our institution (6-9), The other section of
the biopsy specimen was quickly weighed and frozen in
liquid nitrogen. The specimen was homogenized in 100 JLI
of freshly prepared cold 0.4 N perchloric acid/mg wet weight
of the tissue containing 5 mM reduced glutathione in a
microhomogenizer submerged in an ice bath and then cen-
trifuged in a refrigerated centrifuge at 4°C for 20 minutes
at 30,000 g. An aliquot (10 to 100 JLI) of the clear super-
natant was directly injected into the double column, which
was composed of an upper anion exchange column of CDR-
20 (quarternary ammonium anion exchanger with average
particle size 9 JLm) (Mitsubishi Chemical Co.) and a lower
cation exchange column of Zipax SCX (Du Pont Instruments
Co.). The mobile phase was 0.07 N, sodium phosphate
(NaH2P04) with a flow rate of 0.8 mllmin. The separated
catecholamines then entered a continuous flow system de-
scribed previously (6), and the reagents for the trihydroxy-
indole method were added sequentially at a constant flow
rate with the use of a proportioning pump. Because per-
chloric acid caused no adverse effect on the detector system
(trihydroxyindole reaction), tissue extracts were used with-
out neutralization. Finally, the fluorescent products were
applied to a highly sensitive spectrofluorophotometer.
The plasma catecholamine concentrations were deter-
mined by the high peformance liquid chromatographic method
described in a previous report (7), The blood samples for
the determination of catecholamines were drawn through an
indwelling catheter in a peripheral vein after the patient had
been resting for at least 30 minutes on a day close to the
cardiac catheterization study.
Histologic study. For histologic studies, the biopsy spec-
imen was fixed in 10% formalin, dehydrated with graded
ethanol and embedded in paraffin. The paraffin block was
cut in 4 JL sections by a microtome, and the sections were
stained with hematoxylin-eosin, elastic Van Gieson, periodic
acid-Schiff or Masson trichrome,
The shortest diameters of cardiocytes were measured only
in nucleated transverse sections, More than 30 myocardial
cells in each specimen were measured by an ocular mi-
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centrations of norepinephrine and epinephrine in this spec-
imen are 920 and 340 pg/mg wet weight , respectively. These
values are lower for norepinephrine and higher for epi-
nephrine than is usual in hypertrophic cardiomyopathy.
Catecholamine concentrations in myocardial biopsy
specimens (Tables I to 4) . Myocard ial and plasma cate-
cholamine concentrations, diameters of myocytes and grade
of fibrosis in each subgroup of patients are shown in Tables
I to 4. The mean norepinephrine concentration in the left
ventricular myocardium was significantly lower (p < 0.05)
in congestive than in hypertrophic cardiomyopathy. There
was no significant difference in the mean norepinephrine
concentration in either the right or left ventricular myocar-
dium between the patients with hypertrophi c cardio-
myopathy and those with other heart disease . The mean
myocardial epinephrine concentration showed no significant
difference among the three subgroups .
Biopsy specimens were removed fr om both the right and
left ventricle in 14 patients. Norepinephrine concentration
was always significantly higher in the right than in the left
ventricle (p < 0.01) . The mean diameter of the cardiocytes
was 17 ± 3 JLm in the right ventricle and 22 ± 3 JLm in
the left. This differen ce was also statistically significant (p
< 0.001) .
Plasma catecholamine concentrations in patients of
each subgroup (Tables I to 4). The mean plasma nor-
epinephrine and epinephrine concentrations in patients with
heart disease other than cardiomyopathy (noncardiomyopa-
thy group) were 177 ± 47 and 16 ± 3 pg/ml, respectively,
which are within the normal range by our method . In patients
with congestive cardiomyopathy, the concentrations were
402 ± 151 and 78 ± 58 pg/rnl , respectively, which were
significantly higher than those in patients with hypertrophi c
Table 1. Results in 10 Patients With Congestive Cardiomyopathy
cardiomyopathy (207 ± 58 and 22 ± 14 pg/ml, respec-
tively) (p < 0.001 for norepinephirine and < 0.05 for epi-
nephrine). The mean plasma norepinephrine and epineph-
rine levels were also significantly higher in patients with
congestive cardiomyopath y than in patients with other heart
disease (p < 0.001 for norepinephrine and < 0.05 for
epinephrine).
Relation between myocardial norepinephrine concen-
tration and diameter of myocardial cells (Fig. 2 to 4).
The myocardial norepinephrine concentration showed a close
inverse correlation (I' = - 0.86, P < 0.005; regression
equation: Y == 4,223 - 201X) with the diameter of the
myocardial cells obtained from the patients with heart dis-
ease other than cardiomyopathy (Fig. 2). The inverse re-
lation was also statistically significant, but less so in patients
with congestive cardiomyopathy (I' = -0.55, P < 0.05;
regression equation : Y = 1,416 - 40X) (Fig. 3). There
was no significant inverse correlation in patients with hy-
pertrophic card iomyopathy (Fig. 4). There were two patients
(Cases 12 and 13) with hypertrophic cardiomyopathy with
exceptionally high levels of myocardial norepinephrine, re-
gardless of the mean fiber width of the myocardial cells .
The mean diameters of cardiocytes in the right ventricle
were significantly larger in the patients with congestive and
hypertrophic cardiomyopathy than in those with other heart
disease (p < 0.05 ) (Table 4).
Relation between myocardial norepinephrine concen-
tration and grade of interstitial fibrosis (Fig. 5). Generally,
as the grade of interstitial fibrosis increases, myocardial
norepinephrine concentration decreases. There were six
specimens, two from the left ventricle and four from the
right ventricle in five patients with congestive cardio-
myopathy, in which low concentrations of myocardial nor-
Myocardial
Catecholamines
Plasma(pglmg wet weight) Diameter of
Myocytes Grade of Catecholammes NYHA Functional Class
Age (yr)
NE Epi (urn) Fibrosis (pg/rnl)
On EF
Case &Sex RV LV RV LV RV LV RV LV NE Epi Admission At Biopsy (%)
I 44M 365 III 26 II 623 127 IV II 27
2a 36M 819 203 8 4 18 26 0 II 352 74 III II 40
2b 698 4 18 0
3 38M 871 55 23 0 240 25 II II 54
4 60F 312 5 18 II 702 213 II II
5 58M 625 18 14 II 425 83 III II 42
6a 37M 972 69 53 19 18 25 I II 350 45 I I 23
6b 833 45 19 0
7 25M 1,100 8 16 I 295 37 IV II
8 47M 900 600 10 8 18 25 I II 295 42 II II 26
9 58M 490 632 8 IO 16 23 0 II 442 101 III III 17
10 43M 1,016 232 5 4 12 19 I 0 298 40 II II 37
EF = ejection fraction; Epi = epmephrinc; F = female; I = slight fibrosis; II = moderate to severe fibrosis; LV = left ventricle; M = male; NE
= norepinephrine; NYHA = New York Heart ASSOCiation; RV = right ventricle; - = not measured; 0 = no fibrosis.
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Table 2. Results in 24 Patients With Hypertrophic Cardiomyopathy
Myocardial
Catecholarrunes
(pg/mg wet weight) Diameter of Plasma
Myocytes Grade of Catecholamines
Age (yr)
NE Epl (urn) Fibrosis (pg/ml)
Case &Sex RV LV RV LV RV LV RV LV NE Epi
la 55M 1,400 868 25 21 20 20 I 185 12
Ib 1,020 20 20 I
2 52M 1,950 1,337 26 17 20 23 0 143 25
3 31M 706 11 20 I 192 18
4 47M 2,160 8 17 0 112 14
5 39M 1,004 15 20 I 222 15
6 19M 1,404 14 20 I
7 37M 920 340 26 I
8 52M 1,516 1,110 22 26 20 21 I 135 18
9a 37M 1,238 1,110 7 17 14 18 1 141 12
9b 1,143 13 18 I
10 44M 620 460 18 15 18 29 I II 285 24
11 58M 64 4 25 II
12 57M 1,760 (4,810) 250 (20) 14 (18) 0 II 218 19
13 34M (7,930) 500 10 (15) 18 II I
14 50M 708 60 17 I 158 21
15 49M 653 9 17 I 254 15
16 52M 438 10 16 II
17 47M 626 8 16 I 252 18
18a 55M 1,094 5 17 II 184 16
18b
19 58M 1,188 8 22 II 218 19
20 50M 469 8 17 II 223 40
21 42M 250 5 22 II 356 72
22 50F 1,963 10 17 0 235 16
23 48M 1,200 1,062 8 3 20 24 II I 194 15
24 50M 1,000 556 10 13 18 20 II II 225 32
Figures in parentheses indicate values not included for statistical analysis. Abbreviations as in Table 1.
epinephrine were present despite minimal interstitial fibro-
sis. The mean value of norepinephrine concentration in these
specimens was 657 ± 250 pg/mg wet weight, definitely
lower than that in the specimens from the patients with
hypertrophic cardiomyopathy and other heart disease with
minimal interstitial fibrosis. The mean value in the latter
group was 1,959 ± 142 pg/mg wet weight. The average
diameter of the myocardial cells was 19 pm in the former
and 14 pm in the latter group.
Discussion
Methodologic problems. The recent introduction of
highly sensitive, specific techniques for measuring cate-
cholamines has allowed us to determine the concentration
of myocardial norepinephrine and epinephrine in a small
piece of biopsy specimen obtained from the right or left
ventricle during routine diagnostic cardiac catheterization.
Whether catecholamine levels in a small piece of biopsy
specimen represent those of the entire ventricle is a sub-
stantial problem in biopsy studies. Norepinephrine concen-
trations in the specimens removed from different sites of
the right or left ventricle in the same patient showed little
variation (coefficient of variation 7.6%, n = 6, Tables I
to 3). However, some heterogeneities of myocardial inner-
vation, particularly in hearts that are heavily fibrosed, may
cause an inevitable risk that the biopsy specimen does not
represent myocardial catecholamine concentrations through-
out the ventricle. Moreover, there may be a sampling error
in that the histologic features of one sample and the cate-
cholamines measured in a separate sample in the same pa-
tient might not match.
In previous studies (10, 11), very low concentrations of
norepinephrine were demonstrated in atrial tissues and ven-
tricular muscles removed during operation on patients with
heart failure. The norepinephrine concentration was also
markedly depressed in papillary muscles removed from the
left ventricle of patients undergoing mitral valve replace-
ment who had been in severe left ventricular failure (12).
The role of catecholamines appears to be important in
determining the pathogenesis of cardiomyopathy. Deter-
mination of the norepinephrine concentration in the myo-
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Tab le 3. Results in II Patie nts With Other Heart Diseases
Myocardial
Catecholamines
Diameter of Plasma
(pg/rng wet weight)
Myocytes
Grad e of
Catecholamines
NE Epi (u rn)
Fibrosis
(pg/rnl)
Age (yr)
Case &Sex RV LV RV LV RV LV RV LV NE Epl
Acute Perimyocardu is
IBM 1,367 17 12 113 13
2 19M 1,472 16 14 234 2 1
Postrnyocarditis
3 34F 529 15 20 II 185 14
4 28M 720 5 17 II 127 15
5 14M 889 7 16 1 232 16
6a 45M 564 400 4 3 16 19 II 22 1 15
6b 608 476 3 8 15 18 II
7 25M 883 5 16 I
8 57F 1,960 145 10 0
Constricti ve Pericardit is
9 53M 2,690 32 II 132 2 1
Coronary Arteriovenou s FIstula
10 44F 1,474 5 15 199 15
Alcoholism
I I 42M 1,024 6 13 154 18
Abbrevtations as in Tab le I .
cardium removed at operation , however. may be meaning-
less because of the influence of anesthesia and other non-
physiologic proced ures. Biopsy specimens obtained during
routine diagnostic cardiac catetherization certainly provide
information under far more physiologic circumstances .
Morever, myocardial catecholarnines can be investigated
only in biopsy specimens in patients with congestive car-
diomyopathy, in whom cardiac surgery is rarely indicated.
Myocardial norepinephrine concentration in conges-
tive cardiomyopathy. The mean myocardial norepineph-
rine concen tration in mg wet weight of tissue in the left
ventricular myocardium was lower in patients with conges-
Table 4. Myocardial Norepinephrine Concentrations , Diameters of Cardiocytes and Plasma Catecholamines
(mean ± sta ndard deviation)
Myocardial
Norepinephrine Card iocyte Plasma
(pg/rng Diameter Catecholamines
wet weight) (u rn) (pg/ml)
RV LV RV LV NE Epi
CCM 739 ± 265 435 == 311] 18 ±4 J 24 ± 3 ~2 ±151 ]j 78±58~(n = 11) (n = 6) * (n = 10) t (n = 10) *
HCM 1095 ± 562 875 :!: 348 18 ± 3} * 22 ± 3 207 :!: 58 t 22 ± 14 '
( n = 21) (n = 12) (n = 19) (n = 19)
Other 1182 ± 649 438 15 ± 3 19 177 :!: 47 16 ± 3
(n = 12) (n = 2) (n = 9) (n = 9)
Total n = 44 n = 20
*p< 0 .05 . t p<O.OOI .
CCM = congestive cardiomyopathy; Epi epmephnne; HCM = hypertrophic cardiomyopathy; NE = norepinephrine. other = other diseases ;
other abbreviations as in Table 1
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Figure 2. Relation between myocardial norepinephrine concen-
tration andmean fiber width ofcardiocytes in II patients (14 biopsy
specimens) with heart diseases other than cardiomyopathy (non-
cardiomyopathy group). LV = left ventricular and RV = right
ventricular biopsy.
Figure 4. Relation between myocardial norepinephrine concen-
tration andmean fiber width ofcardiocytes in24patients (35 biopsy
specimens) with hypertrophic cardiomyopathy (H[O)CM).
Figure 3. Relation between myocardial norepinephrine concen-
tration andmean fiber width ofcardiocytes in 10patients (17 biopsy
specimens) with congestive cardiomyopathy (CCM). Abbrevia-
tions as in Figure 2.
tive than in those with hypertrophic cardiomyopathy. How-
ever, the present study failed to show larger stores of myo-
cardial norepinephrine in patients with hypertrophic car-
diomyopathy than in those with noncardiomyopathic heart
disease.
Decreased myocardial levels of norepinephrine stores in
congestive cardiomyopathy may well be the result of heart
failure. This is supported by the fact that the mean plasma
norepinephrine and epinephrine levels were significantly
higher in patients with congestive cardiomyopathy than in
those with hypertrophic cardiomyopathy or other heart dis-
ease. It is conceivable, therefore, that patients with conges-
tive cardiomyopathy were at least in latent heart failure,
although there was no obvious evidence of heart failure at
the time of the study.
Mechanism of myocardial norepinephrine depletion
in heart failure. The mechanism of cardiac norepinephrine
depletion in heart failure is still controversial. In dogs with
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Figure 5. Relation between myocardial norepinephrine concen-
tration andthegrade of interstitial fibrosis in45patients (66 biopsy
specimens). Abbreviations as before.
right ventricular failure, the reduction of cardiac norepi-
nephrine concentration was shown not to be the result of a
simple dilution of sympathetic nerve endings in a hypertro-
phied muscle mass, because the total ventricular content of
norepinephrine was lower in both the hypertrophied right
and nonhypertrophied left ventricle (13). Marked reduction
in the activity of tyrosine hydroxylase was considered to be
responsible for the cardiac norepinephrine depletion through
decreased biosynthesis (14). On the other hand, in cardio-
myopathic Syrian hamsters the rate constant for cardiac nor-
epinephrine turnover was much higher than in the control
group. Thus, in the late stage of hamster cardiomyopathy,
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the increase in cardiac sympathetic tone is responsible for
the decrease in cardiac norepinephrine (15). Our results may
also indicate that the myocardial norepinephrine level in no
way provides us with a biochemical index of myocardial
sympathetic activity. In the hamster with cardiomyopathy,
moreover, there is an increase rather than a decrease of
tyrosine hydroxlase activity during the development of heart
failure (16). Although there is clear evidence of depletion
in cardiac norepinephrine in heart failure, the specific mech-
anism responsible for it has not been clarified.
Role of myocardial hypertrophy and interstitial fi-
brosis. The present study indicates that the diameter of the
myocardial cells (grade of myocardial hypertrophy) and the
grade of interstitial fibrosis should always be taken into
account in evaluating myocardial norepinephrine concen-
trations, because the reduction of norepinephrine concen-
tration in the myocardium may be the result of a simple
dilution of sympathetic nerve endings in a hypertrophied
muscle mass (17) or an increase in interstitial fibrosis, or
both. The lower value of the myocardial norepinephrine
concentration in the left than in the right ventricle may be
explained by the simple dilution of sympathetic nerve end-
ings in the left ventricular myocardial cells, which have
larger diameters than those in the right. It is worthwhile to
note that the simple dilution theory holds true in patients
with heart disease other than cardiomyopathy, whose myo-
cardium showed fairly normal histologic features. In pa-
tients with hypertrophic cardiomyopathy, there was no sig-
nificant inverse correlation between the diameter of the
myocardial cells and myocardial norepinephrine concentra-
tions. This is partly because there were some patients wich
exceptionally high concentrations of myocardial norepi-
nephrine, regardless of the cell diameter and the grade of
interstitial fibrosis. In some patients with congestive car-
diomyopathy, however, the level of myocardial norepi-
nephrine was lower than would be expected for the degree
of hypertrophy, interstitial fibrosis or severity of heart failure.
Implications. These findings suggest that abnormal myo-
cardial norepinephrine (a depletion in congestive cardio-
myopathy and an increase in some cases of hypertrophic
cardiomyopathy) may be related to the development of car-
diomyopathy. The regulation of beta-adrenergic receptor
density in the myocardium and, therefore, sensitivity to
catecholamine should also be clarified for a better under-
standing of its role in abnormal myocardial catecholamine
activity in cardiomyopathy. The results of two recent im-
portant studies (18,19) on receptor density in failing hearts
are conflicting. The obvious differences between these two
studies appear to be the duration and cause of heart failure
and the species examined. Further studies in this field are
essential to elucidate more precisely the role of myocardial
catecholamine in the pathogenesis of cardiomyopathy.
We thank Alice S. Cary, MD for pertinent advice on the manuscript.
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